Trial Will Investigate Drug Duo in Solid Cancers With MAPK Pathway Aberrations
Clinical Trial to Assess Experimental Drug as Single-Agent, and Combined With Keytruda Across Several Solid Tumors Launches
I Was Blindsided by a Cancer I’ve Never Heard Of
The Integration of Complementary Cancer Care May ‘Accelerate’ in Coming Years, Says Patrick Dempsey